Nutrition proteomics and biomarker discovery

    Research output: Contribution to journalEditorial

    8 Citations (Scopus)

    Abstract

    Baukje de Roos is a principal investigator at the University of Aberdeen, Rowett Institute of Nutrition and Health. She investigates mechanisms through which dietary fats and fatty acids, and also polyphenols, affect parameters involved in the development of heart disease in vivo. This is achieved not only by measuring their effect on conventional risk markers for heart disease but also by assessing their effect on new markers that are being developed through proteomic and mass spectrometry methods. She obtained her PhD in Human Nutrition at Wageningen University, The Netherlands, in January 2000, after which she was appointed as a post-doctoral research fellow at the Department of Vascular Biochemistry, Glasgow Royal Infirmary, in collaboration with GlaxoSmithKline. In June 2001 she joined the Rowett Research Institute in Aberdeen. She is currently working for the University of Aberdeen, where her research is funded by the Scottish Government Rural and Environment Research and Analysis Directorate (RERAD). She is an active member of the European Nutrigenomics Organisation (NuGO), an EU-funded Network of Excellence, which merges the nutrigenomics activities of its 23 partners across Europe.

    Original languageEnglish
    Pages (from-to)349-351
    Number of pages3
    JournalExpert Review of Proteomics
    Volume6
    Issue number4
    DOIs
    Publication statusPublished - Aug 2009

    Keywords

    • human plasma
    • mice
    • disease
    • cells

    Cite this

    Nutrition proteomics and biomarker discovery. / De Roos, Baukje.

    In: Expert Review of Proteomics, Vol. 6, No. 4, 08.2009, p. 349-351.

    Research output: Contribution to journalEditorial

    @article{1d47f8b2fe6848369fc1b4c5acd4a5ea,
    title = "Nutrition proteomics and biomarker discovery",
    abstract = "Baukje de Roos is a principal investigator at the University of Aberdeen, Rowett Institute of Nutrition and Health. She investigates mechanisms through which dietary fats and fatty acids, and also polyphenols, affect parameters involved in the development of heart disease in vivo. This is achieved not only by measuring their effect on conventional risk markers for heart disease but also by assessing their effect on new markers that are being developed through proteomic and mass spectrometry methods. She obtained her PhD in Human Nutrition at Wageningen University, The Netherlands, in January 2000, after which she was appointed as a post-doctoral research fellow at the Department of Vascular Biochemistry, Glasgow Royal Infirmary, in collaboration with GlaxoSmithKline. In June 2001 she joined the Rowett Research Institute in Aberdeen. She is currently working for the University of Aberdeen, where her research is funded by the Scottish Government Rural and Environment Research and Analysis Directorate (RERAD). She is an active member of the European Nutrigenomics Organisation (NuGO), an EU-funded Network of Excellence, which merges the nutrigenomics activities of its 23 partners across Europe.",
    keywords = "human plasma, mice, disease, cells",
    author = "{De Roos}, Baukje",
    year = "2009",
    month = "8",
    doi = "10.1586/EPR.09.52",
    language = "English",
    volume = "6",
    pages = "349--351",
    journal = "Expert Review of Proteomics",
    issn = "1478-9450",
    publisher = "TAYLOR & FRANCIS LTD",
    number = "4",

    }

    TY - JOUR

    T1 - Nutrition proteomics and biomarker discovery

    AU - De Roos, Baukje

    PY - 2009/8

    Y1 - 2009/8

    N2 - Baukje de Roos is a principal investigator at the University of Aberdeen, Rowett Institute of Nutrition and Health. She investigates mechanisms through which dietary fats and fatty acids, and also polyphenols, affect parameters involved in the development of heart disease in vivo. This is achieved not only by measuring their effect on conventional risk markers for heart disease but also by assessing their effect on new markers that are being developed through proteomic and mass spectrometry methods. She obtained her PhD in Human Nutrition at Wageningen University, The Netherlands, in January 2000, after which she was appointed as a post-doctoral research fellow at the Department of Vascular Biochemistry, Glasgow Royal Infirmary, in collaboration with GlaxoSmithKline. In June 2001 she joined the Rowett Research Institute in Aberdeen. She is currently working for the University of Aberdeen, where her research is funded by the Scottish Government Rural and Environment Research and Analysis Directorate (RERAD). She is an active member of the European Nutrigenomics Organisation (NuGO), an EU-funded Network of Excellence, which merges the nutrigenomics activities of its 23 partners across Europe.

    AB - Baukje de Roos is a principal investigator at the University of Aberdeen, Rowett Institute of Nutrition and Health. She investigates mechanisms through which dietary fats and fatty acids, and also polyphenols, affect parameters involved in the development of heart disease in vivo. This is achieved not only by measuring their effect on conventional risk markers for heart disease but also by assessing their effect on new markers that are being developed through proteomic and mass spectrometry methods. She obtained her PhD in Human Nutrition at Wageningen University, The Netherlands, in January 2000, after which she was appointed as a post-doctoral research fellow at the Department of Vascular Biochemistry, Glasgow Royal Infirmary, in collaboration with GlaxoSmithKline. In June 2001 she joined the Rowett Research Institute in Aberdeen. She is currently working for the University of Aberdeen, where her research is funded by the Scottish Government Rural and Environment Research and Analysis Directorate (RERAD). She is an active member of the European Nutrigenomics Organisation (NuGO), an EU-funded Network of Excellence, which merges the nutrigenomics activities of its 23 partners across Europe.

    KW - human plasma

    KW - mice

    KW - disease

    KW - cells

    U2 - 10.1586/EPR.09.52

    DO - 10.1586/EPR.09.52

    M3 - Editorial

    VL - 6

    SP - 349

    EP - 351

    JO - Expert Review of Proteomics

    JF - Expert Review of Proteomics

    SN - 1478-9450

    IS - 4

    ER -